Abiopharma

🔍 WARREN KELCY L (Executive)

Company: Energy Transfer LP (ET)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 352,032 shares of Common Units at $21.27 per share (Direct)
  Date: 2026-08-18 | Code: P | equity_swap_involved: false | shares_owned_after: 147,253,911.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 647,968 shares of Common Units at $21.26 per share (Direct)
  Date: 2026-08-19 | Code: P | equity_swap_involved: false | shares_owned_after: 147,901,879.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Common Units (Direct)
  Date: 2026-08-18 | Code: H | shares_owned_after: 14,978,717.00
• Holds 0 shares of Common Units (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By: Kelcy Warren Partners II, LP | shares_owned_after: 10,224,429.00 | Footnotes: F4
• Holds 0 shares of Common Units (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By: Kelcy Warren Partners III, LLC | shares_owned_after: 133,136,757.00 | Footnotes: F8
• Holds 0 shares of Common Units (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By: Warren Capital Corp. | shares_owned_after: 1,233,857.00 | Footnotes: F5
• Holds 0 shares of Common Units (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By: ET Company, Ltd. | shares_owned_after: 328,383.00 | Footnotes: F6
• Holds 0 shares of Common Units (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By: LE GP, LLC | shares_owned_after: 601,076.00 | Footnotes: F7

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $21.175 to $21.30, inclusive. The reporting person undertakes to provide to ET, any security holder of ET, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of units purchased at each separate price within this range.
• F2: The reported units are owned directly by Kelcy Warren Partners, LP, a limited partnership owned by Mr. Warren. Mr. Warren disclaims beneficial ownership of the reported units except to the extent of his pecuniary interest therein.
• F3: The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions at prices ranging from $21.185 to $21.30, inclusive. The reporting person undertakes to provide to ET, any security holder of ET, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of units purchased at each separate price within this range.
• F4: The reported units are owned directly by Kelcy Warren Partners II, LP, a limited partnership owned by Mr. Warren. Mr. Warren disclaims beneficial ownership of the reported units except to the extent of his pecuniary interest therein.
• F5: The reported units are owned directly by Warren Capital Corp., a corporation owned by Mr. Warren. Mr. Warren disclaims beneficial ownership of the reported units except to the extent of his pecuniary interest therein.
• F6: The reported units are owned directly by ET Company Ltd. The reported units represent the estimated pro rata interest of Mr. Warren in ET Company Ltd., including through his interest therein held through Three Dawaco, Inc. Mr. Warren disclaims beneficial ownership of the reported units except to the extent of his pecuniary interest therein.
• F7: The reported units are owned directly by LE GP, LLC. The reported units represent his estimated pro rata interest in LE GP, LLC. Mr. Warren disclaims beneficial ownership of the reported units except to the extent of his pecuniary interest therein.
• F8: The reported units are owned directly by Kelcy Warren Partners III, LLC (formerly known as Seven Bridges Holdings LLC) a limited liability company owned by Mr. Warren.